Robert Wynands, PhD

I have over 30 years of experience in small molecule and biologic drug discovery and development across Europe and the USA, with extensive expertise in regulatory filings and project management within both biotech and large pharmaceutical companies. I believe in empowering teams to focus on their strengths without distraction, a leadership approach that has made me a trusted resource for managers globally, particularly at the San Diego site. My career highlights include managing a small molecule IND submission, implementing Excel-based tracking systems that evolved into a global single source of truth at Takeda, and setting up high-throughput protein purification methods as part of a crystal structure determination platform, which contributed to the sale of Syrrx to Takeda for $270M in 2005. I also designed and validated APIs for approved products such as Elonva and Puregon/Follistim.